Lista de obras - Ye H Oo - Dominio Público Uruguay

Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.

artículo científico publicado en 2010

Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease

artículo científico publicado en 2010

Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties

artículo científico publicado en 2010

Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score

artículo científico publicado en 2005

Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy

artículo científico publicado en 2016

Autoimmune hepatitis: an approach to disease understanding and management

artículo científico publicado en 2015

Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management

artículo científico publicado en 2010

Bidirectional Cross-Talk between Biliary Epithelium and Th17 Cells Promotes Local Th17 Expansion and Bile Duct Proliferation in Biliary Liver Diseases

scientific article published on 07 August 2019

Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1.

artículo científico publicado en 2015

CD161(+)CD4(+) T cells are enriched in the liver during chronic hepatitis and associated with co-secretion of IL-22 and IFN-γ

artículo científico publicado en 2012

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans

artículo científico publicado en 2015

Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives

artículo científico publicado en 2016

Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium.

artículo científico publicado en 2011

Corrigendum to "Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy".

artículo científico publicado en 2016

Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients.

artículo científico publicado en 2016

Distinct Roles for CCR4 and CXCR3 in the Recruitment and Positioning of Regulatory T Cells in the Inflamed Human Liver

artículo científico publicado en 2010

Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance

artículo científico publicado en 2015

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

artículo científico publicado en 2014

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

article

Flares during long-term entecavir therapy in chronic hepatitis B.

artículo científico publicado en 2016

HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression

artículo científico publicado en 2016

HLA and outcome in living donor liver transplantation in primary biliary cirrhosis: A new piece in the jigsaw?

artículo científico publicado en 2006

Hepatocellular carcinoma surveillance in hepatitis B virus-infected individuals: Who and how?

artículo científico publicado en 2015

Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells

artículo científico publicado en 2011

Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score.

artículo científico publicado en 2017

Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis

artículo científico publicado en 2016

Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales

artículo científico publicado en 2005

Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.

artículo científico publicado en 2015

Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease

artículo científico publicado en 2015

Low-Dose Interleukin-2 and HCV-Induced Vasculitis

artículo científico publicado en 2012

Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases

artículo científico publicado en 2017

MAIT cells are activated during human viral infections

artículo científico publicado en 2016

Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics

artículo científico publicado en 2012

Mycophenolate mofetil as second line therapy in autoimmune hepatitis?

artículo científico publicado en 2008

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

artículo científico publicado en 2012

Options for treatment of primary biliary cirrhosis

artículo científico publicado en 2004

Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.

artículo científico publicado en 2015

Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.

artículo científico publicado en 2010

Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice

artículo científico publicado en 2014

Persistent pyrexia post-liver transplantation: a unique case of pericardial tuberculosis.

artículo científico publicado en 2008

Rapid recovery of cytochrome P450 3A4 after protease inhibitor withdrawal in post-liver transplant patients

artículo científico publicado en 2012

Recruitment mechanisms of primary and malignant B cells to the human liver

artículo científico publicado en 2012

Regulatory T cells and autoimmune hepatitis: Defective cells or a hostile environment?

artículo científico publicado en 2012

Regulatory T cells and autoimmune hepatitis: What happens in the liver stays in the liver

artículo científico publicado en 2014

Regulatory T-cell directed therapies in liver diseases.

artículo científico

Renal Effects of Cadmium Intake of a Japanese General Population in Two Areas Unpolluted by Cadmium

artículo científico publicado en 2000

Reply

artículo científico publicado en 2016

Supporting evidence for natural killer T cell accumulation in progressive nonalcoholic fatty liver disease?

artículo científico publicado en 2010

Symptomatic portal biliopathy: a single centre experience from the UK

artículo científico publicado en 2009

Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation

artículo científico publicado en 2008

The regulation of T-cell recruitment to the human liver during acute liver failure

artículo científico publicado en 2013

The role of chemokines in the recruitment of lymphocytes to the liver

artículo científico publicado en 2010

The role of chemokines in the recruitment of lymphocytes to the liver

artículo científico publicado en 2010

Vδ2 T Cells-Two Subsets for the Price of One

artículo científico publicado en 2018

WITHDRAWN: Reply

artículo científico publicado en 2016

Lista de obras de Ye H Oo

Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.

Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease

Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties

Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score

Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy

Autoimmune hepatitis: an approach to disease understanding and management

Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management

Bidirectional Cross-Talk between Biliary Epithelium and Th17 Cells Promotes Local Th17 Expansion and Bile Duct Proliferation in Biliary Liver Diseases

Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1.

CD161(+)CD4(+) T cells are enriched in the liver during chronic hepatitis and associated with co-secretion of IL-22 and IFN-γ

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans

Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives

Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium.

Corrigendum to "Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy".

Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients.

Distinct Roles for CCR4 and CXCR3 in the Recruitment and Positioning of Regulatory T Cells in the Inflamed Human Liver

Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

Flares during long-term entecavir therapy in chronic hepatitis B.

HBV core promoter mutations and AKT upregulate S-phase kinase-associated protein 2 to promote postoperative hepatocellular carcinoma progression

HLA and outcome in living donor liver transplantation in primary biliary cirrhosis: A new piece in the jigsaw?

Hepatocellular carcinoma surveillance in hepatitis B virus-infected individuals: Who and how?

Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells

Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score.

Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis

Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales

Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.

Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease

Low-Dose Interleukin-2 and HCV-Induced Vasculitis

Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases

MAIT cells are activated during human viral infections

Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics

Mycophenolate mofetil as second line therapy in autoimmune hepatitis?

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

Options for treatment of primary biliary cirrhosis

Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.

Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.

Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice

Persistent pyrexia post-liver transplantation: a unique case of pericardial tuberculosis.

Rapid recovery of cytochrome P450 3A4 after protease inhibitor withdrawal in post-liver transplant patients

Recruitment mechanisms of primary and malignant B cells to the human liver

Regulatory T cells and autoimmune hepatitis: Defective cells or a hostile environment?

Regulatory T cells and autoimmune hepatitis: What happens in the liver stays in the liver

Regulatory T-cell directed therapies in liver diseases.

Renal Effects of Cadmium Intake of a Japanese General Population in Two Areas Unpolluted by Cadmium

Reply

Supporting evidence for natural killer T cell accumulation in progressive nonalcoholic fatty liver disease?

Symptomatic portal biliopathy: a single centre experience from the UK

Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation

The regulation of T-cell recruitment to the human liver during acute liver failure

The role of chemokines in the recruitment of lymphocytes to the liver

The role of chemokines in the recruitment of lymphocytes to the liver

Vδ2 T Cells-Two Subsets for the Price of One

WITHDRAWN: Reply